These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A role for Grb2-associated binder-1 in growth hormone signaling. Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613 [TBL] [Abstract][Full Text] [Related]
3. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. Kim SO; Jiang J; Yi W; Feng GS; Frank SJ J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080 [TBL] [Abstract][Full Text] [Related]
4. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. VanderKuur J; Allevato G; Billestrup N; Norstedt G; Carter-Su C J Biol Chem; 1995 Mar; 270(13):7587-93. PubMed ID: 7535773 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues. Thirone AC; Carvalho CR; Saad MJ Endocrinology; 1999 Jan; 140(1):55-62. PubMed ID: 9886807 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo. Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909 [TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation. Liang L; Jiang J; Frank SJ Endocrinology; 2000 Sep; 141(9):3328-36. PubMed ID: 10965905 [TBL] [Abstract][Full Text] [Related]
9. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling. Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778 [TBL] [Abstract][Full Text] [Related]
10. G120K-PEG, a human GH antagonist, decreases GH signal transduction in the liver of mice. Thirone AC; Carvalho CR; Saad MJ Mol Cell Endocrinol; 2002 Jun; 192(1-2):65-74. PubMed ID: 12088868 [TBL] [Abstract][Full Text] [Related]
11. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468 [TBL] [Abstract][Full Text] [Related]
12. Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Frank SJ; Gilliland G; Kraft AS; Arnold CS Endocrinology; 1994 Nov; 135(5):2228-39. PubMed ID: 7956946 [TBL] [Abstract][Full Text] [Related]
13. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B. Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797 [TBL] [Abstract][Full Text] [Related]
14. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683 [TBL] [Abstract][Full Text] [Related]
15. Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1. Wang X; Yang N; Deng L; Li X; Jiang J; Gan Y; Frank SJ Mol Endocrinol; 2009 Apr; 23(4):486-96. PubMed ID: 19164446 [TBL] [Abstract][Full Text] [Related]
16. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins. Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. Argetsinger LS; Hsu GW; Myers MG; Billestrup N; White MF; Carter-Su C J Biol Chem; 1995 Jun; 270(24):14685-92. PubMed ID: 7782332 [TBL] [Abstract][Full Text] [Related]
18. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts. Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010 [TBL] [Abstract][Full Text] [Related]
19. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes. Mur C; Valverde AM; Kahn CR; Benito M Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675 [TBL] [Abstract][Full Text] [Related]
20. Modulation of growth hormone signal transduction in kidneys of streptozotocin-induced diabetic animals: effect of a growth hormone receptor antagonist. Thirone AC; Scarlett JA; Gasparetti AL; Araujo EP; Lima MH; Carvalho CR; Velloso LA; Saad MJ Diabetes; 2002 Jul; 51(7):2270-81. PubMed ID: 12086960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]